Safety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma
Clinical trial NCT03113266 · UNKNOWN
Trial details
- NCT number
- NCT03113266
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-06
- Primary completion
- 2020-03-15
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.